GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TAL1
|
ENSG00000162367.7 | TAL bHLH transcription factor 1, erythroid differentiation factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TAL1 | hg19_v2_chr1_-_47697387_47697457 | 0.31 | 3.7e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_42811986 | 57.76 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
chr11_-_5248294 | 51.88 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr17_+_38083977 | 50.16 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr22_+_23040274 | 48.19 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr7_+_30960915 | 47.43 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr14_+_95078714 | 43.15 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr1_-_182360918 | 42.74 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
chr17_+_1665345 | 41.44 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr17_+_77681075 | 40.40 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
chr2_-_218808771 | 40.32 |
ENST00000449814.1
ENST00000171887.4 |
TNS1
|
tensin 1 |
chr19_-_17185848 | 40.32 |
ENST00000593360.1
|
HAUS8
|
HAUS augmin-like complex, subunit 8 |
chr22_+_22681656 | 38.53 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr7_+_150497569 | 38.23 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
chr22_+_23165153 | 38.09 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr8_-_27457494 | 37.53 |
ENST00000521770.1
|
CLU
|
clusterin |
chr1_-_182360498 | 36.89 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
chr5_-_42812143 | 36.26 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr7_+_150497491 | 33.90 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
chr7_-_150497621 | 33.49 |
ENST00000434545.1
|
TMEM176B
|
transmembrane protein 176B |
chr3_-_195310802 | 32.62 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr6_-_170101749 | 32.18 |
ENST00000448612.1
|
WDR27
|
WD repeat domain 27 |
chr2_-_86333244 | 31.92 |
ENST00000263857.6
ENST00000409681.1 |
POLR1A
|
polymerase (RNA) I polypeptide A, 194kDa |
chr3_+_153839149 | 30.89 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr11_-_62457371 | 30.17 |
ENST00000317449.4
|
LRRN4CL
|
LRRN4 C-terminal like |
chr4_+_76439665 | 29.83 |
ENST00000508105.1
ENST00000311638.3 ENST00000380837.3 ENST00000507556.1 ENST00000504190.1 ENST00000507885.1 ENST00000502620.1 ENST00000514480.1 |
THAP6
|
THAP domain containing 6 |
chr22_-_45559642 | 29.57 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
chr3_+_10206545 | 29.31 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
chr17_+_1665253 | 27.76 |
ENST00000254722.4
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr1_+_153004800 | 27.65 |
ENST00000392661.3
|
SPRR1B
|
small proline-rich protein 1B |
chr5_+_134240588 | 27.55 |
ENST00000254908.6
|
PCBD2
|
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 |
chr9_+_124088860 | 27.51 |
ENST00000373806.1
|
GSN
|
gelsolin |
chr22_+_23134974 | 27.49 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr19_+_33182823 | 27.04 |
ENST00000397061.3
|
NUDT19
|
nudix (nucleoside diphosphate linked moiety X)-type motif 19 |
chr3_-_138763734 | 26.85 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
chr7_+_150498610 | 26.45 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
chr3_-_196065248 | 26.27 |
ENST00000446879.1
ENST00000273695.3 |
TM4SF19
|
transmembrane 4 L six family member 19 |
chr1_-_182361327 | 25.91 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
chr13_-_88323218 | 25.73 |
ENST00000436290.2
ENST00000453832.2 ENST00000606590.1 |
MIR4500HG
|
MIR4500 host gene (non-protein coding) |
chr22_+_23248512 | 25.69 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr19_-_6690723 | 25.61 |
ENST00000601008.1
|
C3
|
complement component 3 |
chr14_-_106209368 | 24.57 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr2_-_89310012 | 24.44 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr21_-_46330545 | 24.24 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr7_-_150497406 | 24.10 |
ENST00000492607.1
ENST00000326442.5 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
chr14_-_106926724 | 23.51 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
chr17_+_1674982 | 23.30 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr16_-_55867146 | 23.13 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
chr2_-_89157161 | 22.88 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
chr17_-_5138099 | 22.88 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
chr4_-_48018580 | 22.82 |
ENST00000514170.1
|
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
chr14_-_107078851 | 22.81 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
chr4_+_74718906 | 22.68 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
chr11_+_57365150 | 22.58 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr22_+_23101182 | 22.56 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr4_+_175204818 | 22.53 |
ENST00000503780.1
|
CEP44
|
centrosomal protein 44kDa |
chr17_+_41857793 | 22.38 |
ENST00000449302.3
|
C17orf105
|
chromosome 17 open reading frame 105 |
chr14_-_106322288 | 22.07 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr14_-_100070363 | 21.99 |
ENST00000380243.4
|
CCDC85C
|
coiled-coil domain containing 85C |
chr9_-_93405352 | 21.89 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr14_-_106406090 | 21.88 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr18_+_74240610 | 21.66 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
chr11_+_61891445 | 21.55 |
ENST00000394818.3
ENST00000533896.1 ENST00000278849.4 |
INCENP
|
inner centromere protein antigens 135/155kDa |
chr11_-_111783919 | 21.48 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
chr9_+_139871948 | 21.19 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr19_-_6720686 | 20.97 |
ENST00000245907.6
|
C3
|
complement component 3 |
chr4_+_48018781 | 20.83 |
ENST00000295461.5
|
NIPAL1
|
NIPA-like domain containing 1 |
chr2_+_74120094 | 20.81 |
ENST00000409731.3
ENST00000345517.3 ENST00000409918.1 ENST00000442912.1 ENST00000409624.1 |
ACTG2
|
actin, gamma 2, smooth muscle, enteric |
chr4_-_17812309 | 20.74 |
ENST00000382247.1
ENST00000536863.1 |
DCAF16
|
DDB1 and CUL4 associated factor 16 |
chr7_-_99569468 | 20.68 |
ENST00000419575.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
chr2_+_90139056 | 20.56 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr16_+_1290725 | 20.50 |
ENST00000461509.2
|
TPSAB1
|
tryptase alpha/beta 1 |
chr11_-_5255696 | 20.45 |
ENST00000292901.3
ENST00000417377.1 |
HBD
|
hemoglobin, delta |
chr6_+_31554636 | 20.38 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
chr6_-_159420780 | 20.23 |
ENST00000449822.1
|
RSPH3
|
radial spoke 3 homolog (Chlamydomonas) |
chr18_-_74728998 | 20.23 |
ENST00000359645.3
ENST00000397875.3 ENST00000397869.3 ENST00000578193.1 ENST00000578873.1 ENST00000397866.4 ENST00000528160.1 ENST00000527041.1 ENST00000526111.1 ENST00000397865.5 ENST00000382582.3 |
MBP
|
myelin basic protein |
chr4_+_106629929 | 20.21 |
ENST00000512828.1
ENST00000394730.3 ENST00000507281.1 ENST00000515279.1 |
GSTCD
|
glutathione S-transferase, C-terminal domain containing |
chr5_-_1295104 | 20.18 |
ENST00000334602.6
ENST00000508104.2 ENST00000310581.5 ENST00000296820.5 |
TERT
|
telomerase reverse transcriptase |
chr3_-_167813672 | 20.11 |
ENST00000470487.1
|
GOLIM4
|
golgi integral membrane protein 4 |
chr15_+_90777424 | 20.05 |
ENST00000561433.1
ENST00000559204.1 ENST00000558291.1 |
GDPGP1
|
GDP-D-glucose phosphorylase 1 |
chr14_-_107131560 | 20.04 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr14_-_21270995 | 19.93 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr2_-_85555086 | 19.93 |
ENST00000444342.2
ENST00000409232.3 ENST00000409015.1 |
TGOLN2
|
trans-golgi network protein 2 |
chr19_+_18208603 | 19.79 |
ENST00000262811.6
|
MAST3
|
microtubule associated serine/threonine kinase 3 |
chr14_-_107219365 | 19.65 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr12_-_54982300 | 19.64 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr14_-_21270561 | 19.59 |
ENST00000412779.2
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr3_-_122134882 | 19.44 |
ENST00000330689.4
|
WDR5B
|
WD repeat domain 5B |
chr9_+_91933726 | 19.42 |
ENST00000534113.2
|
SECISBP2
|
SECIS binding protein 2 |
chr9_-_34710066 | 19.37 |
ENST00000378792.1
ENST00000259607.2 |
CCL21
|
chemokine (C-C motif) ligand 21 |
chr5_+_170288856 | 19.34 |
ENST00000523189.1
|
RANBP17
|
RAN binding protein 17 |
chr2_+_89999259 | 19.23 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr14_-_106781017 | 19.22 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chrX_+_55478538 | 19.17 |
ENST00000342972.1
|
MAGEH1
|
melanoma antigen family H, 1 |
chr14_-_106539557 | 19.03 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
chr7_-_150038704 | 18.98 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
chr11_+_1874200 | 18.94 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr12_-_11548496 | 18.88 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
chr18_+_21693306 | 18.82 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
chrX_+_46937745 | 18.79 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
chr6_+_123110302 | 18.76 |
ENST00000368440.4
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A |
chr1_+_220960033 | 18.60 |
ENST00000366910.5
|
MARC1
|
mitochondrial amidoxime reducing component 1 |
chr3_+_167453493 | 18.51 |
ENST00000295777.5
ENST00000472747.2 |
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
chr16_+_1290694 | 18.45 |
ENST00000338844.3
|
TPSAB1
|
tryptase alpha/beta 1 |
chr17_-_41465674 | 18.44 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
chr6_+_123110465 | 18.31 |
ENST00000539041.1
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A |
chr10_+_106034884 | 18.31 |
ENST00000369707.2
ENST00000429569.2 |
GSTO2
|
glutathione S-transferase omega 2 |
chr16_-_3306587 | 18.26 |
ENST00000541159.1
ENST00000536379.1 ENST00000219596.1 ENST00000339854.4 |
MEFV
|
Mediterranean fever |
chr4_-_168155169 | 18.20 |
ENST00000534949.1
ENST00000535728.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr10_-_105452917 | 17.97 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
chr19_+_57831829 | 17.95 |
ENST00000321545.4
|
ZNF543
|
zinc finger protein 543 |
chr16_-_55866997 | 17.87 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
chr12_-_91574142 | 17.81 |
ENST00000547937.1
|
DCN
|
decorin |
chr6_-_33048483 | 17.79 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr19_+_8478154 | 17.71 |
ENST00000381035.4
ENST00000595142.1 ENST00000601724.1 ENST00000393944.1 ENST00000215555.2 ENST00000601283.1 ENST00000595213.1 |
MARCH2
|
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase |
chr12_+_130554803 | 17.68 |
ENST00000535487.1
|
RP11-474D1.2
|
RP11-474D1.2 |
chr19_+_45409011 | 17.63 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr7_-_150498426 | 17.51 |
ENST00000447204.2
|
TMEM176B
|
transmembrane protein 176B |
chr7_+_150498783 | 17.51 |
ENST00000475536.1
ENST00000468689.1 |
TMEM176A
|
transmembrane protein 176A |
chr14_+_102027688 | 17.48 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chr19_-_33793430 | 17.34 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr1_-_20306909 | 17.33 |
ENST00000375111.3
ENST00000400520.3 |
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid) |
chr2_+_95691417 | 17.23 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
chr8_-_120685608 | 17.22 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr20_+_34043085 | 17.09 |
ENST00000397527.1
ENST00000342580.4 |
CEP250
|
centrosomal protein 250kDa |
chr16_+_84209539 | 17.08 |
ENST00000569735.1
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
chr12_+_57146233 | 17.04 |
ENST00000554643.1
ENST00000556650.1 ENST00000554150.1 ENST00000554155.1 |
HSD17B6
|
hydroxysteroid (17-beta) dehydrogenase 6 |
chrX_-_107018969 | 16.99 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr7_-_158622210 | 16.99 |
ENST00000251527.5
|
ESYT2
|
extended synaptotagmin-like protein 2 |
chr22_+_23264766 | 16.94 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr4_+_156587979 | 16.85 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr22_+_23247030 | 16.75 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr19_+_35521572 | 16.71 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr16_-_1843720 | 16.57 |
ENST00000415638.3
ENST00000215539.3 |
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit |
chr14_+_73704201 | 16.54 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
chr20_+_55904815 | 16.38 |
ENST00000371263.3
ENST00000345868.4 ENST00000371260.4 ENST00000418127.1 |
SPO11
|
SPO11 meiotic protein covalently bound to DSB |
chr11_-_66725837 | 16.35 |
ENST00000393958.2
ENST00000393960.1 ENST00000524491.1 ENST00000355677.3 |
PC
|
pyruvate carboxylase |
chr11_+_124492749 | 16.30 |
ENST00000531667.1
ENST00000441174.3 ENST00000375005.4 |
TBRG1
|
transforming growth factor beta regulator 1 |
chr19_+_18794470 | 16.17 |
ENST00000321949.8
ENST00000338797.6 |
CRTC1
|
CREB regulated transcription coactivator 1 |
chr19_-_51531272 | 16.16 |
ENST00000319720.7
|
KLK11
|
kallikrein-related peptidase 11 |
chr10_-_90712520 | 16.10 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr8_+_134125727 | 16.09 |
ENST00000521107.1
|
TG
|
thyroglobulin |
chr5_-_139944196 | 16.06 |
ENST00000357560.4
|
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr1_+_24882560 | 16.04 |
ENST00000374392.2
|
NCMAP
|
noncompact myelin associated protein |
chr16_-_33647696 | 16.03 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
chr4_-_168155300 | 16.00 |
ENST00000541637.1
|
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr4_+_75858318 | 15.99 |
ENST00000307428.7
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
chr19_+_5681011 | 15.92 |
ENST00000581893.1
ENST00000411793.2 ENST00000301382.4 ENST00000581773.1 ENST00000423665.2 ENST00000583928.1 ENST00000342970.2 ENST00000422535.2 ENST00000581521.1 ENST00000339423.2 |
HSD11B1L
|
hydroxysteroid (11-beta) dehydrogenase 1-like |
chr1_+_13910194 | 15.90 |
ENST00000376057.4
ENST00000510906.1 |
PDPN
|
podoplanin |
chr4_-_57522598 | 15.81 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr20_-_35492048 | 15.81 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
chr18_+_39766626 | 15.80 |
ENST00000593234.1
ENST00000585627.1 ENST00000591199.1 ENST00000586990.1 ENST00000593051.1 ENST00000593316.1 ENST00000591381.1 ENST00000585639.1 ENST00000589068.1 |
LINC00907
|
long intergenic non-protein coding RNA 907 |
chr11_-_111781454 | 15.79 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr14_-_94856987 | 15.70 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr20_-_524362 | 15.70 |
ENST00000460062.2
ENST00000608066.1 |
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide |
chr4_-_681114 | 15.64 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
chr20_-_18774614 | 15.63 |
ENST00000412553.1
|
LINC00652
|
long intergenic non-protein coding RNA 652 |
chr10_-_48438974 | 15.59 |
ENST00000224605.2
|
GDF10
|
growth differentiation factor 10 |
chr4_-_87374283 | 15.54 |
ENST00000361569.2
|
MAPK10
|
mitogen-activated protein kinase 10 |
chr11_-_117747434 | 15.52 |
ENST00000529335.2
ENST00000530956.1 ENST00000260282.4 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr22_-_27620603 | 15.47 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
chr4_-_57522673 | 15.47 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr22_+_23241661 | 15.39 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr1_-_15735925 | 15.39 |
ENST00000427824.1
|
RP3-467K16.4
|
RP3-467K16.4 |
chr14_-_106967788 | 15.38 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr11_-_111781610 | 15.37 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr11_+_2421718 | 15.33 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr22_+_23243156 | 15.32 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr11_-_5255861 | 15.28 |
ENST00000380299.3
|
HBD
|
hemoglobin, delta |
chr4_+_156588115 | 15.25 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr19_-_36643329 | 15.25 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
chr19_-_11669960 | 15.19 |
ENST00000589171.1
ENST00000590700.1 ENST00000586683.1 ENST00000593077.1 ENST00000252445.3 |
ELOF1
|
elongation factor 1 homolog (S. cerevisiae) |
chr14_-_94856951 | 15.13 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr19_-_57183114 | 15.11 |
ENST00000537055.2
ENST00000601659.1 |
ZNF835
|
zinc finger protein 835 |
chr16_-_30032610 | 15.06 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr1_-_47407111 | 15.00 |
ENST00000371904.4
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
chr11_-_117698765 | 14.96 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
chr12_+_69201923 | 14.93 |
ENST00000462284.1
ENST00000258149.5 ENST00000356290.4 ENST00000540827.1 ENST00000428863.2 ENST00000393412.3 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
chr14_+_22446680 | 14.87 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
chr1_+_169337172 | 14.82 |
ENST00000367807.3
ENST00000367808.3 ENST00000329281.2 ENST00000420531.1 |
BLZF1
|
basic leucine zipper nuclear factor 1 |
chr17_+_48610074 | 14.79 |
ENST00000503690.1
ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3
|
epsin 3 |
chr2_+_90108504 | 14.71 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr1_-_40237020 | 14.70 |
ENST00000327582.5
|
OXCT2
|
3-oxoacid CoA transferase 2 |
chr2_+_189839046 | 14.69 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
chr2_+_95691445 | 14.67 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
chr19_+_2977444 | 14.65 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
chr11_-_114466477 | 14.63 |
ENST00000375478.3
|
NXPE4
|
neurexophilin and PC-esterase domain family, member 4 |
chr11_-_117747607 | 14.62 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr3_+_40566369 | 14.60 |
ENST00000403205.2
ENST00000310898.1 ENST00000339296.5 ENST00000431278.1 |
ZNF621
|
zinc finger protein 621 |
chr15_-_49338624 | 14.60 |
ENST00000261847.3
ENST00000380927.2 ENST00000559424.1 |
SECISBP2L
|
SECIS binding protein 2-like |
chr17_-_26695013 | 14.59 |
ENST00000555059.2
|
CTB-96E2.2
|
Homeobox protein SEBOX |
chr15_+_75118888 | 14.55 |
ENST00000395018.4
|
CPLX3
|
complexin 3 |
chr17_-_42402138 | 14.49 |
ENST00000592857.1
ENST00000586016.1 ENST00000590194.1 ENST00000377095.5 ENST00000588049.1 ENST00000586633.1 ENST00000537904.2 ENST00000585636.1 ENST00000585523.1 ENST00000225308.8 |
SLC25A39
|
solute carrier family 25, member 39 |
chr19_+_57742431 | 14.46 |
ENST00000302804.7
|
AURKC
|
aurora kinase C |
chr15_+_66874502 | 14.46 |
ENST00000558797.1
|
RP11-321F6.1
|
HCG2003567; Uncharacterized protein |
chr20_+_57267669 | 14.45 |
ENST00000356091.6
|
NPEPL1
|
aminopeptidase-like 1 |
chr1_-_161277210 | 14.44 |
ENST00000491222.2
|
MPZ
|
myelin protein zero |
chr6_-_32908765 | 14.41 |
ENST00000416244.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
chr1_-_11866034 | 14.36 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr5_-_149535421 | 14.34 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
chr9_+_139873264 | 14.32 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.6 | 106.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
24.0 | 96.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
19.8 | 98.8 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
15.5 | 46.6 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
14.7 | 206.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
13.0 | 52.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
12.0 | 72.2 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
11.1 | 66.8 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
10.3 | 31.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
10.3 | 10.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
10.0 | 30.0 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
9.3 | 27.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
9.2 | 27.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
9.1 | 90.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
9.0 | 27.1 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
8.6 | 8.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
8.4 | 25.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
8.3 | 8.3 | GO:0046755 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
7.6 | 22.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
7.6 | 37.9 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
7.5 | 22.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
7.5 | 30.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
7.5 | 37.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
7.4 | 22.2 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
7.3 | 14.6 | GO:0001300 | chronological cell aging(GO:0001300) |
7.1 | 21.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
7.0 | 42.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
7.0 | 7.0 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
6.8 | 27.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
6.8 | 27.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
6.5 | 13.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
6.5 | 6.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
6.5 | 19.4 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
6.4 | 19.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
6.4 | 31.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
6.3 | 25.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
6.3 | 18.8 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
6.2 | 18.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
6.1 | 18.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
6.1 | 24.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
6.1 | 18.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
6.1 | 861.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
6.0 | 18.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
5.9 | 17.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
5.9 | 23.7 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
5.8 | 17.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
5.6 | 22.5 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
5.6 | 22.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
5.5 | 16.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
5.4 | 16.2 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
5.4 | 10.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
5.4 | 16.2 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
5.4 | 5.4 | GO:0032609 | interferon-gamma production(GO:0032609) |
5.3 | 16.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
5.3 | 21.2 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
5.2 | 5.2 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) ketone body metabolic process(GO:1902224) |
5.2 | 15.6 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
5.2 | 15.5 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
5.1 | 20.6 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
5.0 | 15.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
5.0 | 24.8 | GO:0035106 | operant conditioning(GO:0035106) |
5.0 | 19.9 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
4.9 | 14.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
4.9 | 29.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
4.9 | 24.4 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
4.8 | 19.3 | GO:0060023 | soft palate development(GO:0060023) |
4.8 | 14.3 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
4.8 | 4.8 | GO:0014719 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
4.8 | 14.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
4.7 | 14.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
4.7 | 18.8 | GO:1904640 | response to methionine(GO:1904640) |
4.6 | 32.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
4.6 | 9.2 | GO:0032526 | response to retinoic acid(GO:0032526) |
4.6 | 9.2 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
4.6 | 13.7 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
4.5 | 22.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
4.5 | 13.4 | GO:0019732 | antifungal humoral response(GO:0019732) |
4.5 | 22.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
4.4 | 44.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
4.4 | 13.2 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
4.4 | 17.6 | GO:0006710 | androgen catabolic process(GO:0006710) |
4.4 | 4.4 | GO:0045937 | positive regulation of phosphorus metabolic process(GO:0010562) positive regulation of phosphate metabolic process(GO:0045937) |
4.3 | 4.3 | GO:0051255 | spindle midzone assembly(GO:0051255) |
4.3 | 13.0 | GO:0010193 | response to ozone(GO:0010193) |
4.3 | 4.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
4.3 | 21.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
4.3 | 4.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
4.2 | 12.7 | GO:0051946 | regulation of amino acid import(GO:0010958) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
4.2 | 88.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
4.2 | 46.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
4.2 | 12.5 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
4.1 | 8.3 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
4.1 | 16.6 | GO:0007525 | somatic muscle development(GO:0007525) |
4.1 | 16.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
4.1 | 20.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
4.1 | 8.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
4.0 | 20.2 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
4.0 | 12.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.9 | 11.8 | GO:1904395 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
3.9 | 11.7 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
3.9 | 19.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
3.9 | 31.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
3.9 | 7.8 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
3.9 | 11.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
3.8 | 11.4 | GO:0097359 | UDP-glucosylation(GO:0097359) |
3.8 | 22.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
3.8 | 11.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
3.8 | 11.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
3.7 | 7.5 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
3.7 | 11.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
3.7 | 22.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
3.7 | 7.4 | GO:0070781 | response to biotin(GO:0070781) |
3.7 | 7.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
3.7 | 7.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
3.6 | 65.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
3.6 | 14.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
3.6 | 18.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.6 | 43.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.6 | 10.7 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
3.6 | 10.7 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
3.5 | 17.7 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
3.5 | 17.6 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
3.5 | 10.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
3.5 | 21.0 | GO:0001554 | luteolysis(GO:0001554) |
3.5 | 10.5 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
3.5 | 3.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
3.5 | 73.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
3.5 | 17.3 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
3.5 | 17.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
3.4 | 34.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
3.4 | 16.9 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
3.4 | 3.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
3.4 | 6.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
3.3 | 3.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
3.3 | 3.3 | GO:1904062 | regulation of cation transmembrane transport(GO:1904062) |
3.3 | 6.6 | GO:0005985 | sucrose metabolic process(GO:0005985) |
3.3 | 3.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
3.3 | 9.8 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
3.3 | 3.3 | GO:0014900 | muscle hyperplasia(GO:0014900) |
3.3 | 45.6 | GO:0015671 | oxygen transport(GO:0015671) |
3.3 | 26.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
3.2 | 13.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
3.2 | 6.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
3.2 | 3.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
3.2 | 9.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
3.2 | 9.7 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
3.2 | 19.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
3.2 | 12.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
3.2 | 9.5 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
3.1 | 9.4 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
3.1 | 18.7 | GO:0010269 | response to selenium ion(GO:0010269) |
3.1 | 6.2 | GO:0051414 | response to cortisol(GO:0051414) |
3.0 | 6.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
3.0 | 18.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.0 | 27.2 | GO:0015747 | urate transport(GO:0015747) |
3.0 | 33.1 | GO:0000050 | urea cycle(GO:0000050) |
3.0 | 24.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
3.0 | 9.0 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
3.0 | 6.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
3.0 | 35.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
3.0 | 20.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
3.0 | 8.9 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
3.0 | 26.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
2.9 | 5.9 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
2.9 | 11.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
2.9 | 5.8 | GO:0060621 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
2.9 | 8.7 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
2.9 | 5.8 | GO:0002215 | defense response to nematode(GO:0002215) |
2.9 | 11.6 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
2.9 | 8.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
2.9 | 11.5 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
2.9 | 42.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
2.9 | 2.9 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
2.8 | 8.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
2.8 | 8.5 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
2.8 | 2.8 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
2.8 | 8.5 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
2.8 | 11.3 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
2.8 | 5.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
2.8 | 11.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.8 | 5.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.8 | 5.5 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.8 | 11.1 | GO:1902617 | response to fluoride(GO:1902617) |
2.8 | 5.5 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
2.8 | 8.3 | GO:0032571 | response to vitamin K(GO:0032571) |
2.8 | 2.8 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
2.7 | 11.0 | GO:0035624 | receptor transactivation(GO:0035624) |
2.7 | 13.7 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
2.7 | 8.2 | GO:0002384 | hepatic immune response(GO:0002384) |
2.7 | 19.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.7 | 2.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.7 | 8.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
2.7 | 51.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
2.7 | 10.8 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.7 | 13.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.7 | 24.1 | GO:0015705 | iodide transport(GO:0015705) |
2.7 | 18.7 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.7 | 10.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
2.7 | 47.8 | GO:0036376 | sodium ion export from cell(GO:0036376) |
2.6 | 2.6 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.6 | 21.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.6 | 26.3 | GO:0060174 | limb bud formation(GO:0060174) |
2.6 | 10.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
2.6 | 10.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.6 | 7.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.6 | 7.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.6 | 2.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
2.6 | 17.9 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
2.5 | 7.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.5 | 7.6 | GO:0071529 | cementum mineralization(GO:0071529) |
2.5 | 7.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
2.5 | 10.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
2.5 | 10.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
2.5 | 42.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
2.5 | 17.6 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
2.5 | 15.0 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
2.5 | 12.5 | GO:0019532 | oxalate transport(GO:0019532) |
2.5 | 2.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.5 | 7.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
2.5 | 7.4 | GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) |
2.5 | 51.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
2.4 | 9.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
2.4 | 21.9 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
2.4 | 24.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
2.4 | 2.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
2.4 | 36.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.4 | 7.2 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
2.4 | 9.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.4 | 2.4 | GO:0042220 | response to cocaine(GO:0042220) |
2.4 | 7.1 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
2.4 | 11.9 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
2.4 | 40.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
2.4 | 7.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
2.4 | 7.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
2.3 | 4.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
2.3 | 11.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.3 | 7.0 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
2.3 | 23.4 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.3 | 7.0 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
2.3 | 16.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
2.3 | 4.6 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
2.3 | 16.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.3 | 9.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.3 | 16.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
2.3 | 11.3 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
2.3 | 61.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
2.3 | 38.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
2.3 | 6.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
2.2 | 15.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
2.2 | 4.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
2.2 | 8.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
2.2 | 11.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
2.2 | 11.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.2 | 24.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
2.2 | 13.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
2.2 | 6.7 | GO:0002818 | intracellular defense response(GO:0002818) |
2.2 | 20.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
2.2 | 6.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
2.2 | 8.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
2.2 | 8.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
2.2 | 13.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
2.2 | 6.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.2 | 11.0 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
2.2 | 11.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
2.2 | 54.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
2.2 | 6.5 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.1 | 8.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.1 | 17.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
2.1 | 6.4 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.1 | 6.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
2.1 | 2.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
2.1 | 77.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
2.1 | 4.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
2.1 | 6.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
2.1 | 10.5 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
2.1 | 12.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.1 | 4.2 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
2.1 | 12.4 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
2.1 | 10.4 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
2.1 | 10.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
2.1 | 8.2 | GO:0015811 | L-cystine transport(GO:0015811) |
2.1 | 4.1 | GO:1903115 | regulation of actin filament-based movement(GO:1903115) |
2.0 | 16.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
2.0 | 4.1 | GO:0036269 | swimming behavior(GO:0036269) |
2.0 | 14.3 | GO:0002933 | lipid hydroxylation(GO:0002933) |
2.0 | 14.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
2.0 | 6.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
2.0 | 14.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
2.0 | 8.1 | GO:1905176 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
2.0 | 4.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
2.0 | 6.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
2.0 | 8.0 | GO:0003335 | corneocyte development(GO:0003335) |
2.0 | 14.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.0 | 7.9 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
2.0 | 4.0 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
2.0 | 2.0 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
2.0 | 15.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
2.0 | 5.9 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
2.0 | 3.9 | GO:0045124 | regulation of bone resorption(GO:0045124) |
2.0 | 5.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.9 | 3.9 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
1.9 | 7.7 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
1.9 | 5.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.9 | 9.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.9 | 30.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.9 | 13.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
1.9 | 5.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.9 | 5.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
1.9 | 9.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
1.9 | 30.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.9 | 3.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
1.9 | 7.5 | GO:0021633 | optic nerve structural organization(GO:0021633) |
1.9 | 11.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.9 | 7.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
1.9 | 1.9 | GO:1990403 | embryonic brain development(GO:1990403) |
1.9 | 5.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.9 | 7.5 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
1.9 | 20.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.9 | 9.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.9 | 5.6 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
1.8 | 12.9 | GO:0045007 | depurination(GO:0045007) |
1.8 | 24.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.8 | 3.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.8 | 9.2 | GO:1904383 | response to sodium phosphate(GO:1904383) |
1.8 | 1.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.8 | 9.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
1.8 | 12.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.8 | 5.5 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.8 | 3.7 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
1.8 | 9.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.8 | 7.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.8 | 3.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.8 | 18.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.8 | 3.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.8 | 18.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.8 | 3.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.8 | 7.2 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.8 | 7.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.8 | 8.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.8 | 14.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.8 | 21.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.8 | 3.5 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
1.8 | 5.3 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
1.7 | 8.7 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
1.7 | 8.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.7 | 5.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
1.7 | 5.2 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.7 | 39.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
1.7 | 5.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.7 | 5.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
1.7 | 8.6 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
1.7 | 1.7 | GO:0070988 | demethylation(GO:0070988) |
1.7 | 10.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.7 | 3.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.7 | 5.1 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
1.7 | 6.8 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
1.7 | 13.5 | GO:0060073 | micturition(GO:0060073) |
1.7 | 11.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
1.7 | 16.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.7 | 10.0 | GO:0044241 | lipid digestion(GO:0044241) |
1.7 | 8.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.7 | 18.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.7 | 8.3 | GO:0042737 | drug catabolic process(GO:0042737) |
1.6 | 19.8 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
1.6 | 27.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.6 | 14.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.6 | 24.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.6 | 3.3 | GO:0022900 | electron transport chain(GO:0022900) |
1.6 | 8.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
1.6 | 6.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.6 | 4.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.6 | 3.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.6 | 6.5 | GO:0032342 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
1.6 | 1.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
1.6 | 9.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.6 | 4.8 | GO:0044804 | nucleophagy(GO:0044804) |
1.6 | 12.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
1.6 | 4.8 | GO:2000439 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
1.6 | 6.4 | GO:2000170 | negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
1.6 | 1.6 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
1.6 | 3.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
1.6 | 3.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
1.6 | 3.2 | GO:0002331 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
1.6 | 4.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.6 | 16.0 | GO:0001825 | blastocyst formation(GO:0001825) |
1.6 | 1.6 | GO:0018377 | protein myristoylation(GO:0018377) |
1.6 | 26.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.6 | 6.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
1.6 | 9.3 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
1.5 | 9.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.5 | 6.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
1.5 | 1.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
1.5 | 7.7 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
1.5 | 4.6 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
1.5 | 4.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.5 | 3.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
1.5 | 12.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.5 | 6.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.5 | 6.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.5 | 4.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
1.5 | 7.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
1.5 | 4.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.5 | 4.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
1.5 | 5.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.5 | 5.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.5 | 4.4 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
1.5 | 5.9 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.5 | 4.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.5 | 4.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.5 | 4.4 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
1.5 | 8.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.5 | 4.4 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.5 | 1.5 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
1.5 | 17.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.5 | 14.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.4 | 52.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.4 | 14.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.4 | 10.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
1.4 | 4.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
1.4 | 4.3 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
1.4 | 8.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.4 | 2.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.4 | 93.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.4 | 5.7 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
1.4 | 2.8 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
1.4 | 2.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.4 | 5.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.4 | 22.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.4 | 2.8 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.4 | 5.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.4 | 7.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.4 | 22.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.4 | 4.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
1.4 | 36.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.4 | 2.8 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.4 | 2.8 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
1.4 | 15.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.4 | 2.8 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
1.4 | 12.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.4 | 6.9 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
1.4 | 6.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
1.4 | 1.4 | GO:0008037 | cell recognition(GO:0008037) |
1.4 | 4.1 | GO:0043132 | NAD transport(GO:0043132) |
1.3 | 14.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.3 | 4.0 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
1.3 | 17.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.3 | 2.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.3 | 5.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
1.3 | 8.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.3 | 4.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.3 | 10.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.3 | 2.6 | GO:0001678 | cellular glucose homeostasis(GO:0001678) |
1.3 | 19.7 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
1.3 | 6.5 | GO:0019323 | pentose catabolic process(GO:0019323) |
1.3 | 3.9 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
1.3 | 18.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
1.3 | 11.7 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
1.3 | 11.7 | GO:0015889 | cobalamin transport(GO:0015889) |
1.3 | 6.5 | GO:0036017 | response to erythropoietin(GO:0036017) |
1.3 | 10.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
1.3 | 18.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
1.3 | 2.6 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
1.3 | 10.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
1.3 | 2.6 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.3 | 5.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.3 | 19.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.3 | 5.1 | GO:0042426 | choline catabolic process(GO:0042426) |
1.3 | 3.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.3 | 11.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
1.3 | 3.8 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
1.3 | 11.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.2 | 6.2 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.2 | 5.0 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.2 | 19.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.2 | 1.2 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
1.2 | 9.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.2 | 41.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.2 | 17.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
1.2 | 2.4 | GO:0010827 | regulation of glucose transport(GO:0010827) |
1.2 | 6.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.2 | 49.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.2 | 2.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.2 | 3.6 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
1.2 | 9.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.2 | 4.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.2 | 3.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
1.2 | 10.7 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
1.2 | 5.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.2 | 7.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
1.2 | 10.6 | GO:0032364 | oxygen homeostasis(GO:0032364) |
1.2 | 7.1 | GO:0008272 | sulfate transport(GO:0008272) |
1.2 | 1.2 | GO:0009624 | response to nematode(GO:0009624) |
1.2 | 5.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.2 | 12.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.2 | 5.9 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
1.2 | 5.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.2 | 5.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.2 | 5.8 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
1.2 | 10.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.2 | 3.5 | GO:0051715 | cytolysis in other organism(GO:0051715) |
1.2 | 2.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.2 | 3.5 | GO:0021586 | pons maturation(GO:0021586) |
1.2 | 3.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
1.2 | 3.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.2 | 6.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.2 | 9.2 | GO:0001675 | acrosome assembly(GO:0001675) |
1.1 | 5.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
1.1 | 3.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.1 | 5.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.1 | 58.2 | GO:0006953 | acute-phase response(GO:0006953) |
1.1 | 5.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.1 | 1.1 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
1.1 | 3.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
1.1 | 3.4 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
1.1 | 3.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.1 | 1.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.1 | 4.5 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
1.1 | 12.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.1 | 12.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
1.1 | 7.9 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
1.1 | 3.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
1.1 | 3.4 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.1 | 8.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.1 | 3.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.1 | 3.3 | GO:1905065 | mineralocorticoid receptor signaling pathway(GO:0031959) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.1 | 6.6 | GO:0008354 | germ cell migration(GO:0008354) |
1.1 | 3.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
1.1 | 3.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.1 | 27.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
1.1 | 6.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.1 | 4.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.1 | 14.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
1.1 | 3.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.1 | 9.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.1 | 6.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
1.1 | 7.5 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
1.1 | 9.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.1 | 7.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.1 | 1.1 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.1 | 3.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.1 | 9.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.1 | 2.1 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
1.1 | 3.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
1.1 | 8.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
1.1 | 19.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
1.1 | 8.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.1 | 8.4 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
1.1 | 33.7 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
1.0 | 14.7 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
1.0 | 2.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.0 | 5.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
1.0 | 2.1 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
1.0 | 4.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.0 | 2.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.0 | 28.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.0 | 6.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.0 | 11.3 | GO:0015074 | DNA integration(GO:0015074) |
1.0 | 15.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.0 | 3.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.0 | 7.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.0 | 11.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.0 | 23.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
1.0 | 4.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
1.0 | 1.0 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
1.0 | 4.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.0 | 3.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.0 | 4.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.0 | 6.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
1.0 | 134.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.0 | 7.0 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
1.0 | 9.0 | GO:0070571 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
1.0 | 7.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
1.0 | 2.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
1.0 | 4.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.0 | 10.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) depyrimidination(GO:0045008) |
1.0 | 8.9 | GO:0014029 | neural crest formation(GO:0014029) |
1.0 | 5.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.0 | 3.0 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
1.0 | 2.0 | GO:0015824 | proline transport(GO:0015824) |
1.0 | 5.9 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.0 | 10.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.0 | 4.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.0 | 2.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
1.0 | 1.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
1.0 | 4.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.0 | 4.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.0 | 8.8 | GO:2000194 | regulation of female gonad development(GO:2000194) |
1.0 | 11.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
1.0 | 1.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.0 | 9.7 | GO:0030575 | nuclear body organization(GO:0030575) |
1.0 | 4.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
1.0 | 12.6 | GO:0007530 | sex determination(GO:0007530) |
1.0 | 6.8 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.0 | 3.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.0 | 8.7 | GO:0006477 | protein sulfation(GO:0006477) |
1.0 | 2.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.0 | 43.2 | GO:0010761 | fibroblast migration(GO:0010761) |
1.0 | 6.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.0 | 3.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.9 | 1.9 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.9 | 5.7 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.9 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 5.7 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.9 | 31.0 | GO:1990266 | neutrophil migration(GO:1990266) |
0.9 | 10.3 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.9 | 7.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.9 | 1.9 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.9 | 9.3 | GO:0009650 | UV protection(GO:0009650) |
0.9 | 4.6 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.9 | 2.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.9 | 12.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.9 | 8.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.9 | 2.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.9 | 15.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.9 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.9 | 3.6 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.9 | 43.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.9 | 2.7 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.9 | 12.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.9 | 0.9 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.9 | 16.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.9 | 3.5 | GO:0042476 | odontogenesis(GO:0042476) |
0.9 | 6.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.9 | 22.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.9 | 2.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.9 | 2.6 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.9 | 2.6 | GO:0042435 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.9 | 2.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.9 | 2.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.9 | 16.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.9 | 2.6 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.9 | 6.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 6.0 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.8 | 3.4 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.8 | 2.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.8 | 11.0 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.8 | 15.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 2.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.8 | 5.9 | GO:0030335 | positive regulation of cell migration(GO:0030335) |
0.8 | 14.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.8 | 8.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 3.3 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.8 | 1.6 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.8 | 4.9 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
0.8 | 2.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.8 | 1.6 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.8 | 1.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.8 | 1.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.8 | 3.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.8 | 2.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.8 | 1.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.8 | 4.0 | GO:0016311 | dephosphorylation(GO:0016311) |
0.8 | 15.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.8 | 2.4 | GO:0061002 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.8 | 4.0 | GO:2000321 | regulation of memory T cell differentiation(GO:0043380) positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.8 | 1.6 | GO:0061056 | sclerotome development(GO:0061056) |
0.8 | 3.9 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.8 | 6.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.8 | 3.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.8 | 4.7 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.8 | 0.8 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.8 | 1.6 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.8 | 3.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.8 | 1.5 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 1.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.8 | 9.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.8 | 3.8 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.8 | 3.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.8 | 1.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 14.4 | GO:0098743 | cell aggregation(GO:0098743) |
0.8 | 6.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.7 | 3.0 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.7 | 6.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 6.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.7 | 3.7 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.7 | 0.7 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.7 | 2.9 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.7 | 1.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.7 | 10.3 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.7 | 5.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 2.2 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.7 | 6.6 | GO:0070206 | protein trimerization(GO:0070206) |
0.7 | 1.5 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.7 | 8.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.7 | 13.8 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.7 | 10.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.7 | 2.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.7 | 0.7 | GO:0043491 | protein kinase B signaling(GO:0043491) |
0.7 | 7.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.7 | 11.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.7 | 2.9 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.7 | 3.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.7 | 5.7 | GO:0021756 | striatum development(GO:0021756) |
0.7 | 5.7 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.7 | 2.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.7 | 25.5 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.7 | 0.7 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.7 | 1.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.7 | 3.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.7 | 6.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.7 | 7.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.7 | 7.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.7 | 1.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.7 | 3.5 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.7 | 2.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.7 | 6.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.7 | 15.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.7 | 4.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.7 | 3.4 | GO:0043255 | regulation of carbohydrate biosynthetic process(GO:0043255) |
0.7 | 12.1 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.7 | 6.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.7 | 7.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.7 | 4.0 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.7 | 2.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 2.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.7 | 2.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.7 | 7.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.7 | 3.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.7 | 2.0 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.7 | 10.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.6 | 1.9 | GO:1901727 | protein kinase D signaling(GO:0089700) positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
0.6 | 1.9 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) |
0.6 | 9.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.6 | 1.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 12.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.6 | 15.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.6 | 3.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.6 | 23.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.6 | 5.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.6 | 2.5 | GO:0032418 | lysosome localization(GO:0032418) |
0.6 | 2.5 | GO:0072017 | distal tubule development(GO:0072017) |
0.6 | 2.5 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.6 | 18.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.6 | 2.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 | 3.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.6 | 11.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.6 | 15.9 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 4.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 1.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.6 | 6.7 | GO:0003341 | cilium movement(GO:0003341) |
0.6 | 5.5 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.6 | 0.6 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.6 | 9.7 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.6 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.6 | 1.8 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
0.6 | 1.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.6 | 0.6 | GO:0015791 | polyol transport(GO:0015791) |
0.6 | 1.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.6 | 5.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.6 | 4.7 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.6 | 2.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 2.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.6 | 1.2 | GO:0072143 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.6 | 9.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.6 | 4.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.6 | 4.6 | GO:0003094 | glomerular filtration(GO:0003094) |
0.6 | 8.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 2.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.6 | 6.3 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.6 | 2.9 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.6 | 3.4 | GO:0072540 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 cell lineage commitment(GO:0072540) |
0.6 | 3.4 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 3.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.6 | 5.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 1.7 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.6 | 1.7 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.6 | 1.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 7.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.6 | 1.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.6 | 9.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.6 | 2.8 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.6 | 1.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 6.1 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.6 | 1.1 | GO:0021834 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.6 | 1.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.6 | 2.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 2.2 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.5 | 14.7 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.5 | 2.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 3.8 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.5 | 5.3 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.5 | 29.4 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
0.5 | 27.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.5 | 4.8 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.5 | 3.2 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 4.8 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.5 | 2.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.5 | 4.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.5 | 5.8 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 3.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 3.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.5 | 3.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 2.6 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.5 | 0.5 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.5 | 7.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.5 | 5.1 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.5 | 2.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.5 | 1.5 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 4.0 | GO:0019229 | regulation of vasoconstriction(GO:0019229) |
0.5 | 9.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.5 | 2.0 | GO:0006067 | ethanol metabolic process(GO:0006067) |
0.5 | 1.0 | GO:1902750 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.5 | 3.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.5 | 3.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.5 | 4.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.5 | 2.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 7.2 | GO:0097435 | fibril organization(GO:0097435) |
0.5 | 1.0 | GO:0097056 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.5 | 2.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.5 | 1.0 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of macrophage apoptotic process(GO:2000110) |
0.5 | 4.8 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.5 | 3.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.5 | 7.9 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.5 | 2.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.5 | 1.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 3.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 2.7 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.5 | 1.4 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.5 | 2.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.5 | 10.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.5 | 5.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 0.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 4.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.5 | 2.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 0.9 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.4 | 1.8 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.4 | 17.7 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.4 | 13.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.4 | 4.3 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.4 | 3.5 | GO:0043401 | hormone-mediated signaling pathway(GO:0009755) steroid hormone mediated signaling pathway(GO:0043401) |
0.4 | 2.6 | GO:0030421 | defecation(GO:0030421) |
0.4 | 1.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 1.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.4 | 1.7 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.4 | 1.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.4 | 4.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.4 | 7.6 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.4 | 1.7 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.4 | 4.6 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.4 | 4.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 8.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 1.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.4 | 2.5 | GO:0019098 | reproductive behavior(GO:0019098) |
0.4 | 2.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.4 | 5.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 5.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.4 | 2.0 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.4 | 3.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 0.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.4 | 4.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.4 | 3.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.4 | 2.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.4 | 3.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.4 | 1.2 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.4 | 2.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 10.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.4 | 1.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 1.1 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.4 | 2.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.4 | 1.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 2.6 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.4 | 2.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 1.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.4 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 6.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.4 | 2.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 1.8 | GO:0071543 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.4 | 2.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.4 | 1.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 4.0 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.4 | 0.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.3 | 2.4 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 0.3 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.3 | 2.4 | GO:0051938 | L-glutamate import(GO:0051938) amino acid import across plasma membrane(GO:0089718) |
0.3 | 3.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 1.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 1.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 7.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 1.7 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 2.7 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.3 | 0.7 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.3 | 0.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.3 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 6.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.3 | 1.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 3.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.3 | 2.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 2.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.3 | 3.6 | GO:0021510 | spinal cord development(GO:0021510) |
0.3 | 1.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 4.8 | GO:0061647 | histone H3-K9 modification(GO:0061647) |
0.3 | 3.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 1.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 0.6 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.3 | 1.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 3.8 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.3 | 0.9 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.3 | 1.2 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 5.3 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.3 | 1.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 0.9 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 3.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 4.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.9 | GO:2000341 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 1.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 1.5 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.3 | 4.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.3 | 1.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 1.8 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.3 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.6 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 2.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.3 | 0.8 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.8 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
0.3 | 4.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 1.7 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 3.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 1.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 1.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 1.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.3 | 1.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 6.9 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 4.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.3 | 0.8 | GO:0035564 | regulation of kidney size(GO:0035564) regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) pronephros morphogenesis(GO:0072114) |
0.3 | 0.8 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) establishment of meiotic spindle localization(GO:0051295) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.3 | 0.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 0.8 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.3 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 15.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.3 | 1.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 1.3 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.3 | 3.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 4.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.3 | 1.8 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 6.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 1.3 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.3 | 1.8 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.3 | 3.5 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.3 | 2.3 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 3.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 7.2 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.2 | 1.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 3.0 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.2 | 2.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 2.9 | GO:0006833 | water transport(GO:0006833) |
0.2 | 0.7 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.2 | 8.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.7 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.2 | 0.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 2.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 1.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 0.5 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 15.5 | GO:0007586 | digestion(GO:0007586) |
0.2 | 4.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.2 | 0.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 1.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.9 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.2 | 3.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.7 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.2 | 1.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 2.4 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.2 | 1.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 1.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 5.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 0.8 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 0.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 3.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 2.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 3.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 1.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 2.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 4.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 0.8 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.2 | 2.7 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.2 | 0.9 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 1.1 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.2 | 3.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.9 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.2 | 2.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 1.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 2.4 | GO:0042596 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
0.2 | 0.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 1.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 1.8 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.2 | 2.9 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.2 | 5.0 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.2 | 0.7 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.2 | 1.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 1.7 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.2 | 0.5 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.2 | 0.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 0.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 8.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.2 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.2 | 3.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 20.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 1.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.6 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 1.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 16.4 | GO:0007601 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.1 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 2.6 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.3 | GO:0034644 | cellular response to UV(GO:0034644) |
0.1 | 0.6 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 1.0 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 1.0 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.1 | 1.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 2.5 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 3.0 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.1 | 2.1 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 1.4 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.9 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.1 | 1.0 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.1 | 1.4 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.1 | 0.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 1.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 3.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.7 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 1.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 1.0 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.3 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 1.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 1.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 1.1 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.1 | 1.0 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.1 | 0.4 | GO:0019430 | response to superoxide(GO:0000303) removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.7 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 5.5 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 21.9 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 1.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.7 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 1.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.2 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.5 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 0.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 1.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 2.8 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 1.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.4 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 0.4 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.4 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 2.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 1.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 1.4 | GO:0008283 | cell proliferation(GO:0008283) |
0.0 | 0.7 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 1.0 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.3 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.0 | 0.8 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.5 | GO:1905114 | cell surface receptor signaling pathway involved in cell-cell signaling(GO:1905114) |
0.0 | 0.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.9 | GO:0060021 | palate development(GO:0060021) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.5 | 58.6 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
16.8 | 67.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
9.9 | 9.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
9.4 | 112.4 | GO:0043203 | axon hillock(GO:0043203) |
8.0 | 397.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
7.7 | 38.6 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
7.2 | 36.0 | GO:0000801 | central element(GO:0000801) |
7.1 | 7.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
6.8 | 20.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
6.5 | 26.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
6.3 | 43.8 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
6.0 | 83.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
5.8 | 110.7 | GO:0097386 | glial cell projection(GO:0097386) |
5.7 | 56.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
5.5 | 38.7 | GO:0019814 | immunoglobulin complex(GO:0019814) |
5.2 | 82.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
5.0 | 20.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
4.9 | 14.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
4.8 | 101.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
4.7 | 42.7 | GO:0070652 | HAUS complex(GO:0070652) |
4.7 | 14.2 | GO:0036027 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
4.5 | 54.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
4.5 | 17.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
4.2 | 4.2 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
4.2 | 105.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
4.0 | 16.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
3.9 | 19.5 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
3.9 | 11.6 | GO:0002139 | stereocilia coupling link(GO:0002139) |
3.9 | 19.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
3.9 | 27.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
3.7 | 18.7 | GO:0071546 | pi-body(GO:0071546) |
3.6 | 10.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
3.5 | 14.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.4 | 40.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
3.3 | 6.7 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
3.3 | 16.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
3.1 | 12.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
3.1 | 37.5 | GO:0043194 | axon initial segment(GO:0043194) |
3.1 | 3.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
3.0 | 48.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
3.0 | 469.3 | GO:0072562 | blood microparticle(GO:0072562) |
2.9 | 11.7 | GO:0045179 | apical cortex(GO:0045179) |
2.9 | 8.7 | GO:0036398 | TCR signalosome(GO:0036398) |
2.9 | 23.0 | GO:0033010 | paranodal junction(GO:0033010) |
2.8 | 8.5 | GO:0098536 | deuterosome(GO:0098536) |
2.8 | 56.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.7 | 13.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.7 | 18.9 | GO:0097433 | dense body(GO:0097433) |
2.6 | 15.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
2.6 | 31.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
2.5 | 7.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.5 | 32.9 | GO:0033270 | paranode region of axon(GO:0033270) |
2.5 | 20.2 | GO:0032010 | phagolysosome(GO:0032010) |
2.5 | 35.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.5 | 7.4 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
2.4 | 14.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
2.4 | 21.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
2.4 | 7.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
2.3 | 4.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
2.2 | 4.5 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
2.2 | 8.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
2.2 | 37.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.1 | 50.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
2.1 | 12.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
2.1 | 20.5 | GO:0071953 | elastic fiber(GO:0071953) |
2.0 | 8.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
2.0 | 4.0 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
2.0 | 8.0 | GO:1990745 | EARP complex(GO:1990745) |
2.0 | 7.9 | GO:0070695 | FHF complex(GO:0070695) |
2.0 | 27.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
2.0 | 27.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
2.0 | 5.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.9 | 7.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.9 | 9.5 | GO:0031045 | dense core granule(GO:0031045) |
1.9 | 13.3 | GO:0033269 | internode region of axon(GO:0033269) |
1.9 | 13.1 | GO:0033391 | chromatoid body(GO:0033391) |
1.9 | 7.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.8 | 3.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.8 | 23.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.8 | 7.2 | GO:0044194 | cytolytic granule(GO:0044194) |
1.8 | 12.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.7 | 12.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.7 | 32.7 | GO:0001891 | phagocytic cup(GO:0001891) |
1.7 | 13.4 | GO:0035976 | AP1 complex(GO:0035976) |
1.7 | 88.0 | GO:0001533 | cornified envelope(GO:0001533) |
1.7 | 186.8 | GO:0005796 | Golgi lumen(GO:0005796) |
1.6 | 22.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
1.6 | 6.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
1.6 | 6.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.6 | 28.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 10.9 | GO:1990635 | proximal dendrite(GO:1990635) |
1.5 | 30.9 | GO:0005861 | troponin complex(GO:0005861) |
1.5 | 4.6 | GO:0005921 | gap junction(GO:0005921) |
1.5 | 4.6 | GO:0031143 | pseudopodium(GO:0031143) |
1.5 | 1.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
1.5 | 20.8 | GO:0036038 | MKS complex(GO:0036038) |
1.5 | 5.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.5 | 7.4 | GO:0005579 | membrane attack complex(GO:0005579) |
1.5 | 22.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.5 | 8.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.4 | 2.9 | GO:0032421 | stereocilium(GO:0032420) stereocilium bundle(GO:0032421) |
1.4 | 5.7 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
1.4 | 7.1 | GO:0072687 | meiotic spindle(GO:0072687) |
1.4 | 4.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
1.4 | 4.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.4 | 8.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.4 | 12.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.4 | 8.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.3 | 13.3 | GO:0097427 | microtubule bundle(GO:0097427) |
1.3 | 38.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.3 | 3.9 | GO:0060187 | cell pole(GO:0060187) |
1.3 | 2.6 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.3 | 30.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
1.3 | 7.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
1.2 | 9.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.2 | 26.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
1.2 | 6.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
1.2 | 22.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.2 | 7.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.2 | 5.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.2 | 5.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.1 | 16.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.1 | 37.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.1 | 7.4 | GO:0001520 | outer dense fiber(GO:0001520) |
1.1 | 7.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.1 | 7.4 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.1 | 8.4 | GO:0097546 | ciliary base(GO:0097546) |
1.0 | 5.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 34.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.0 | 1.0 | GO:0043291 | RAVE complex(GO:0043291) |
1.0 | 2.0 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
1.0 | 4.0 | GO:0045298 | tubulin complex(GO:0045298) |
1.0 | 4.9 | GO:0031105 | septin complex(GO:0031105) |
1.0 | 25.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
1.0 | 2.9 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.9 | 8.5 | GO:0032797 | SMN complex(GO:0032797) |
0.9 | 6.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.9 | 4.7 | GO:0005883 | neurofilament(GO:0005883) |
0.9 | 11.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.9 | 2.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.9 | 6.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 4.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.9 | 3.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.9 | 4.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.9 | 42.9 | GO:0005902 | microvillus(GO:0005902) |
0.9 | 4.4 | GO:0089701 | U2AF(GO:0089701) |
0.9 | 4.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.9 | 5.2 | GO:1990037 | Lewy body core(GO:1990037) |
0.9 | 3.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 6.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.9 | 8.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.9 | 65.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.9 | 2.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 17.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.9 | 6.0 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 10.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 99.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.8 | 4.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.8 | 3.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.8 | 2.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 46.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.8 | 3.9 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.8 | 107.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.8 | 1028.6 | GO:0005615 | extracellular space(GO:0005615) |
0.8 | 2.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.8 | 4.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.7 | 4.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.7 | 4.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.7 | 4.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.7 | 3.7 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.7 | 1.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.7 | 2.9 | GO:0033176 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) proton-transporting V-type ATPase complex(GO:0033176) |
0.7 | 4.2 | GO:0002177 | manchette(GO:0002177) |
0.7 | 11.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.7 | 3.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.7 | 4.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 6.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.7 | 4.8 | GO:0031906 | late endosome lumen(GO:0031906) multivesicular body lumen(GO:0097486) |
0.7 | 40.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.7 | 10.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 19.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 5.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 22.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.6 | 1.9 | GO:0097447 | dendritic tree(GO:0097447) |
0.6 | 11.2 | GO:0005922 | connexon complex(GO:0005922) |
0.6 | 19.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 37.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.6 | 7.3 | GO:0043218 | compact myelin(GO:0043218) |
0.6 | 3.6 | GO:0016342 | catenin complex(GO:0016342) |
0.6 | 22.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 2.3 | GO:1990031 | pinceau fiber(GO:1990031) |
0.6 | 1.1 | GO:0043260 | laminin-3 complex(GO:0005608) laminin-11 complex(GO:0043260) |
0.6 | 4.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 25.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.5 | 3.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 1.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 8.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 2.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 33.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 1.5 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
0.5 | 7.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.5 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 22.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.5 | 2.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.5 | 15.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 9.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 6.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 0.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.5 | 14.5 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 33.9 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.5 | 2.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 1.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 23.8 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.4 | 16.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 5.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 2.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.6 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.4 | 1.2 | GO:0001652 | granular component(GO:0001652) |
0.4 | 1.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.4 | 1.5 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.4 | 11.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 6.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 6.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.4 | 2.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 11.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 2.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 5.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 1.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.3 | 18.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 5.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 2.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 1.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 3.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 3.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 3.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 9.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 4.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 6.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 3.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 2.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 7.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 3.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 339.2 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.2 | 4.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 5.4 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 1.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 8.0 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 6.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 3.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 474.0 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.2 | 1.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 15.1 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 4.0 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.7 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.4 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 0.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 8.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.5 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.5 | GO:0005816 | equatorial microtubule organizing center(GO:0000923) spindle pole body(GO:0005816) |
0.0 | 0.5 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 3.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 1.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.6 | 106.3 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
15.8 | 47.4 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
11.2 | 67.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
10.9 | 65.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
9.8 | 29.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
9.1 | 36.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
8.6 | 103.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
8.2 | 41.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
7.7 | 46.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
7.5 | 30.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
7.4 | 22.3 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
7.3 | 29.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
7.2 | 397.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
7.2 | 7.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
7.0 | 28.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
6.8 | 27.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
6.7 | 20.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
6.6 | 19.9 | GO:0034584 | piRNA binding(GO:0034584) |
6.5 | 45.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
6.2 | 18.7 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
6.2 | 24.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
6.1 | 18.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
5.6 | 28.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
5.6 | 16.7 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
5.6 | 22.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
5.6 | 61.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
5.2 | 15.5 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
5.1 | 45.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
5.0 | 15.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
4.9 | 19.4 | GO:0001855 | complement component C4b binding(GO:0001855) |
4.8 | 24.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
4.8 | 14.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
4.7 | 18.6 | GO:0008940 | nitrate reductase activity(GO:0008940) |
4.4 | 44.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
4.4 | 13.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
4.4 | 17.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
4.3 | 21.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
4.3 | 8.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
4.3 | 17.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
4.3 | 42.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
4.2 | 105.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
4.1 | 8.3 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
4.0 | 36.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
4.0 | 56.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
4.0 | 23.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
4.0 | 11.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
3.9 | 15.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
3.9 | 11.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
3.9 | 19.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
3.9 | 15.5 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
3.9 | 19.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
3.9 | 3.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
3.9 | 23.2 | GO:0008430 | selenium binding(GO:0008430) |
3.8 | 11.4 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
3.7 | 14.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.7 | 3.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
3.7 | 18.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
3.7 | 7.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
3.7 | 14.7 | GO:0008410 | CoA-transferase activity(GO:0008410) |
3.6 | 10.9 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
3.6 | 14.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
3.5 | 10.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
3.5 | 14.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
3.5 | 10.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
3.5 | 10.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
3.5 | 10.5 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
3.5 | 17.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
3.4 | 17.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
3.4 | 10.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
3.4 | 10.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
3.4 | 16.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
3.4 | 67.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
3.4 | 47.3 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
3.4 | 10.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
3.3 | 13.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
3.3 | 13.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
3.3 | 9.9 | GO:0035473 | lipase binding(GO:0035473) |
3.3 | 9.9 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
3.3 | 19.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
3.3 | 16.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
3.2 | 31.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.2 | 6.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
3.1 | 18.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
3.1 | 15.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
3.1 | 9.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
3.1 | 15.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
3.1 | 31.4 | GO:0009374 | biotin binding(GO:0009374) |
3.1 | 12.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
3.1 | 9.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
3.0 | 18.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.0 | 12.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
3.0 | 18.3 | GO:0047115 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
3.0 | 9.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
3.0 | 45.5 | GO:0015250 | water channel activity(GO:0015250) |
3.0 | 518.1 | GO:0003823 | antigen binding(GO:0003823) |
3.0 | 29.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
3.0 | 8.9 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
3.0 | 11.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.9 | 87.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
2.9 | 8.8 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
2.9 | 32.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.9 | 11.7 | GO:0035939 | microsatellite binding(GO:0035939) |
2.9 | 17.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
2.9 | 11.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
2.9 | 8.7 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
2.9 | 314.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.8 | 8.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
2.8 | 8.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
2.8 | 45.4 | GO:0038191 | neuropilin binding(GO:0038191) |
2.8 | 16.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
2.8 | 11.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
2.8 | 8.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.8 | 36.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.8 | 47.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
2.8 | 33.1 | GO:0045159 | myosin II binding(GO:0045159) |
2.7 | 11.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.7 | 90.2 | GO:0008009 | chemokine activity(GO:0008009) |
2.7 | 8.2 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
2.7 | 16.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
2.6 | 15.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
2.6 | 12.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
2.6 | 12.9 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
2.5 | 7.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.5 | 22.7 | GO:0043426 | MRF binding(GO:0043426) |
2.5 | 15.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.5 | 20.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
2.4 | 7.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.4 | 7.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
2.4 | 7.2 | GO:0032093 | SAM domain binding(GO:0032093) |
2.4 | 28.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
2.4 | 9.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.4 | 9.6 | GO:0017040 | ceramidase activity(GO:0017040) |
2.4 | 7.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
2.4 | 19.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.4 | 7.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
2.4 | 7.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
2.3 | 21.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
2.3 | 21.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.3 | 11.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.3 | 9.2 | GO:1904493 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
2.3 | 16.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.3 | 36.6 | GO:0048156 | tau protein binding(GO:0048156) |
2.3 | 11.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
2.2 | 20.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
2.2 | 6.7 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
2.2 | 11.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
2.2 | 22.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
2.2 | 13.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.2 | 6.6 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
2.2 | 8.8 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
2.2 | 11.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
2.2 | 15.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.2 | 24.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
2.2 | 6.6 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
2.2 | 37.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
2.2 | 8.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.2 | 10.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.2 | 10.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
2.2 | 10.8 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
2.1 | 8.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.1 | 8.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.1 | 17.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
2.1 | 2.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
2.1 | 12.7 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
2.1 | 12.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
2.1 | 6.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
2.1 | 24.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
2.1 | 8.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
2.0 | 20.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
2.0 | 12.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.0 | 10.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
2.0 | 8.1 | GO:0030911 | TPR domain binding(GO:0030911) |
2.0 | 44.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.0 | 16.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
2.0 | 8.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
2.0 | 6.0 | GO:0070052 | collagen V binding(GO:0070052) |
2.0 | 7.8 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
2.0 | 5.9 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
2.0 | 15.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
1.9 | 9.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.9 | 15.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.9 | 11.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.9 | 5.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.8 | 22.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.8 | 5.5 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
1.8 | 11.0 | GO:0003796 | lysozyme activity(GO:0003796) |
1.8 | 5.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
1.7 | 8.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.7 | 6.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.7 | 20.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.7 | 44.9 | GO:0043394 | proteoglycan binding(GO:0043394) |
1.7 | 5.2 | GO:0004040 | amidase activity(GO:0004040) |
1.7 | 6.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
1.7 | 12.0 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.7 | 17.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.7 | 5.1 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
1.7 | 5.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
1.7 | 13.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.7 | 3.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
1.7 | 5.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.7 | 23.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.7 | 1.7 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
1.6 | 4.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.6 | 9.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.6 | 4.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.6 | 24.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.6 | 19.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.6 | 6.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.6 | 6.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.6 | 3.2 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
1.6 | 77.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.6 | 36.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.6 | 334.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.6 | 7.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
1.6 | 4.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.6 | 12.4 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.5 | 10.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.5 | 6.2 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
1.5 | 7.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.5 | 10.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.5 | 3.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.5 | 4.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.5 | 4.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
1.5 | 3.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.5 | 8.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
1.5 | 14.8 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
1.5 | 16.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.5 | 10.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.5 | 4.4 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
1.5 | 38.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.5 | 7.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
1.5 | 7.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.5 | 16.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.5 | 4.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.5 | 10.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
1.5 | 29.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.4 | 27.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.4 | 4.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
1.4 | 2.9 | GO:0043495 | protein anchor(GO:0043495) |
1.4 | 5.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.4 | 5.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.4 | 17.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.4 | 5.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.4 | 15.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.4 | 4.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.4 | 2.8 | GO:0031013 | troponin I binding(GO:0031013) |
1.4 | 7.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.4 | 1.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
1.4 | 4.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.4 | 8.4 | GO:0045569 | TRAIL binding(GO:0045569) |
1.4 | 11.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.4 | 4.2 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.4 | 4.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.4 | 25.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.4 | 4.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
1.4 | 27.7 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
1.4 | 4.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
1.4 | 8.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.4 | 5.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.4 | 6.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
1.4 | 16.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.3 | 13.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.3 | 44.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.3 | 9.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.3 | 22.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.3 | 6.6 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
1.3 | 2.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.3 | 3.9 | GO:0015563 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
1.3 | 5.2 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.3 | 18.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
1.3 | 3.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.3 | 6.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.3 | 7.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
1.3 | 10.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.3 | 3.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.3 | 14.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.3 | 17.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.3 | 28.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.3 | 33.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.3 | 7.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.3 | 10.0 | GO:0004875 | complement receptor activity(GO:0004875) |
1.2 | 14.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.2 | 9.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.2 | 13.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.2 | 51.8 | GO:0015026 | coreceptor activity(GO:0015026) |
1.2 | 4.9 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
1.2 | 3.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
1.2 | 4.9 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
1.2 | 3.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.2 | 9.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.2 | 4.7 | GO:0016499 | orexin receptor activity(GO:0016499) |
1.2 | 8.3 | GO:0089720 | caspase binding(GO:0089720) |
1.2 | 22.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
1.2 | 5.8 | GO:0004359 | glutaminase activity(GO:0004359) |
1.2 | 5.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
1.2 | 3.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.2 | 31.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.2 | 3.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.2 | 6.9 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.2 | 2.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.2 | 12.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.1 | 1.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
1.1 | 7.9 | GO:0016015 | morphogen activity(GO:0016015) |
1.1 | 6.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.1 | 27.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.1 | 14.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.1 | 5.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.1 | 3.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
1.1 | 3.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.1 | 8.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.1 | 3.3 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.1 | 2.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.1 | 18.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 16.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.1 | 4.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.1 | 3.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
1.1 | 1.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.1 | 7.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.1 | 4.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
1.1 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.1 | 6.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.1 | 8.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.0 | 4.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.0 | 5.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.0 | 13.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
1.0 | 5.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
1.0 | 5.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
1.0 | 2.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.0 | 22.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
1.0 | 13.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 4.1 | GO:0030172 | troponin C binding(GO:0030172) |
1.0 | 4.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.0 | 6.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.0 | 24.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.0 | 26.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.0 | 3.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.0 | 8.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.0 | 5.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.0 | 11.9 | GO:0033691 | sialic acid binding(GO:0033691) |
1.0 | 25.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.0 | 46.5 | GO:0030507 | spectrin binding(GO:0030507) |
1.0 | 15.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.0 | 8.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.0 | 10.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.0 | 35.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.0 | 3.9 | GO:0047708 | biotinidase activity(GO:0047708) |
1.0 | 2.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.0 | 6.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.0 | 1.9 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
1.0 | 3.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.0 | 2.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.9 | 2.8 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.9 | 2.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.9 | 3.7 | GO:0016160 | amylase activity(GO:0016160) |
0.9 | 28.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.9 | 13.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.9 | 2.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.9 | 9.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.9 | 7.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.9 | 29.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.9 | 3.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.9 | 5.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.9 | 4.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.9 | 4.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.9 | 6.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.9 | 11.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.9 | 7.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.9 | 18.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.9 | 2.6 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.9 | 6.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.9 | 2.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.9 | 37.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.9 | 23.2 | GO:0042805 | actinin binding(GO:0042805) |
0.9 | 9.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.9 | 9.4 | GO:0016918 | retinal binding(GO:0016918) |
0.8 | 2.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.8 | 3.4 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.8 | 3.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 5.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.8 | 10.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.8 | 14.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.8 | 33.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 2.5 | GO:0001016 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.8 | 3.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.8 | 2.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.8 | 8.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.8 | 7.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.8 | 7.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.8 | 7.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.8 | 12.6 | GO:0019864 | IgG binding(GO:0019864) |
0.8 | 10.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 3.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 3.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.8 | 10.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.8 | 3.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.8 | 4.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.8 | 9.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.8 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.8 | 9.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 2.2 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 4.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.7 | 2.2 | GO:0017129 | triglyceride binding(GO:0017129) |
0.7 | 10.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 2.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.7 | 5.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.7 | 2.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 6.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.7 | 9.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 10.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 4.0 | GO:0016595 | glutamate binding(GO:0016595) |
0.7 | 3.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.7 | 11.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.7 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 9.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.7 | 8.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 2.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.7 | 3.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.6 | 3.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.6 | 5.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 3.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.6 | 3.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 1.9 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.6 | 0.6 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.6 | 14.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.6 | 3.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.6 | 4.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 2.4 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
0.6 | 9.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.6 | 25.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 7.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 49.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.6 | 3.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 15.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 5.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 8.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 1.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.6 | 3.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.6 | 2.3 | GO:0008431 | vitamin E binding(GO:0008431) |
0.6 | 7.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.6 | 1.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 3.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 8.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.6 | 6.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.6 | 3.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.5 | 3.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.5 | 4.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.5 | 2.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.5 | 8.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.5 | 2.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.5 | 10.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 8.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.5 | 2.6 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.5 | 6.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.5 | 6.6 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.5 | 26.6 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.5 | 2.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 4.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 4.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 5.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.5 | 3.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 0.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 3.4 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.5 | GO:0070984 | SET domain binding(GO:0070984) |
0.5 | 1.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 3.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.5 | 1.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.5 | 9.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.5 | 2.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 6.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 16.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.5 | 0.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 5.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 34.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.5 | 2.7 | GO:0005497 | androgen binding(GO:0005497) |
0.5 | 12.2 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.5 | 3.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 3.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.4 | 8.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 7.5 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 30.3 | GO:0005179 | hormone activity(GO:0005179) |
0.4 | 2.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 4.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 3.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 5.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.4 | 4.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 11.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 1.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 5.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.4 | 8.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 2.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 2.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 6.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 6.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 4.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 4.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 1.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 1.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.4 | 3.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.4 | 7.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.4 | 1.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 1.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 5.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 2.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.4 | 3.5 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.4 | 2.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 2.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 1.9 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.4 | 3.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 4.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 1.8 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.4 | 3.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.4 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 2.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.4 | 1.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.4 | 4.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 2.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 36.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 1.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 5.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 2.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 1.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.3 | 5.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 1.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 6.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 41.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.3 | 98.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 2.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 9.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.3 | 3.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 4.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 2.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 4.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 13.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 2.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 2.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 21.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 5.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.3 | 11.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 2.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 7.0 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.7 | GO:0039552 | RIG-I binding(GO:0039552) |
0.3 | 0.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.3 | 1.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.3 | 18.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 1.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 3.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 3.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 3.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 1.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 17.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 4.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 2.2 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 12.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 76.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 2.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 174.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 4.2 | GO:0005254 | chloride channel activity(GO:0005254) |
0.2 | 0.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 2.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 8.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 4.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 7.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 1.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 5.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 0.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.2 | 5.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 0.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.2 | 4.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.2 | 1.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 5.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 2.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.9 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 0.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 1.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 2.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 3.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 10.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 2.0 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.1 | 4.4 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 3.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 4.0 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 15.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 3.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 1.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.1 | 1.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 2.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 3.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 1.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.2 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 6.7 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 26.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
3.2 | 72.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
3.1 | 18.5 | PID ALK1 PATHWAY | ALK1 signaling events |
2.4 | 16.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
2.0 | 27.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
2.0 | 109.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.8 | 1.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.7 | 104.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.7 | 80.7 | NABA COLLAGENS | Genes encoding collagen proteins |
1.7 | 61.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.7 | 16.6 | ST STAT3 PATHWAY | STAT3 Pathway |
1.6 | 50.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.6 | 1.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.6 | 398.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.4 | 26.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.2 | 8.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.2 | 42.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.2 | 41.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.2 | 28.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.2 | 13.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.1 | 7.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.1 | 30.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.1 | 2.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.1 | 35.7 | ST ADRENERGIC | Adrenergic Pathway |
1.0 | 29.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.0 | 18.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.0 | 175.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.0 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 3.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 8.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.9 | 14.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.9 | 32.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.9 | 6.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.9 | 41.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.9 | 16.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.9 | 62.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.9 | 29.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.8 | 25.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 5.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.8 | 12.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.8 | 12.8 | PID EPO PATHWAY | EPO signaling pathway |
0.8 | 3.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.8 | 300.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.8 | 58.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.8 | 5.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.7 | 18.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 29.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 23.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.7 | 12.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.7 | 8.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.7 | 12.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.7 | 3.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 26.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.7 | 5.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 3.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 8.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.6 | 12.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 11.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 10.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 3.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 3.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 46.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 2.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 11.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 2.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.4 | 13.5 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 15.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 2.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 4.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 3.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 7.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 7.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 3.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 8.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 17.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 11.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 3.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 9.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 16.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 5.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 50.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.3 | 1.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 4.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 17.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 5.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 19.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 4.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 6.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 7.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 2.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 121.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
5.3 | 85.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
5.1 | 25.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
4.4 | 61.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
3.1 | 47.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
3.0 | 65.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.9 | 29.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.9 | 46.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
2.8 | 30.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
2.7 | 57.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.6 | 7.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
2.4 | 41.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
2.3 | 128.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
2.3 | 18.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
2.2 | 40.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.2 | 53.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.0 | 67.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.0 | 31.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.9 | 40.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.8 | 67.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.8 | 3.6 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
1.8 | 3.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.7 | 12.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.7 | 66.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.7 | 15.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.7 | 102.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.7 | 28.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.7 | 90.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.7 | 13.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
1.7 | 39.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.6 | 33.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.6 | 29.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.6 | 96.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.6 | 11.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.6 | 4.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.6 | 12.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.5 | 6.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.4 | 60.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.3 | 119.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.3 | 6.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
1.3 | 40.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.3 | 24.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.2 | 28.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.2 | 35.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
1.2 | 11.7 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
1.2 | 28.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.2 | 95.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.1 | 69.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.1 | 7.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.0 | 53.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.0 | 21.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.0 | 2.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.0 | 16.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 8.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.0 | 7.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.9 | 117.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.9 | 12.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.9 | 12.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.8 | 10.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 14.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.8 | 22.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.8 | 15.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.8 | 34.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.8 | 10.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.8 | 15.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 13.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.8 | 33.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.8 | 35.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 44.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.7 | 14.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.7 | 11.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 27.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.7 | 6.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.7 | 16.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.6 | 9.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 15.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 11.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 8.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.6 | 21.8 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.6 | 20.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.6 | 10.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 0.6 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.6 | 22.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 7.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.6 | 7.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.6 | 7.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 6.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.6 | 16.4 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.6 | 19.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 14.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 10.7 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.6 | 1.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 8.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 37.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 5.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 56.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 6.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 12.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 6.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 5.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 3.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 5.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 3.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 5.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 3.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 6.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 27.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 14.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 11.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 8.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 6.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 35.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 1.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 4.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 5.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 10.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 8.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 17.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.3 | 15.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 1.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 10.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 88.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 10.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 6.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 2.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 8.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 2.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 3.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 4.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 1.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 8.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 4.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 7.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 4.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 3.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 3.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 3.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 6.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 8.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 3.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 8.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 2.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |